ARTA
LAB icon

A.R.T. Advisors’s Standard BioTools LAB Stock Holding History

A.R.T. Advisors’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-34,269
Closed -$159K – 1538
2019
Q3 		$159K Buy
34,269
+21,220
+163% +$167K 0.01% 1213
2019
Q2 		$161K Sell
13,049
-63,200
-83% -$805K 0.01% 1139
2019
Q1 		$1.01M Buy
+76,249
New +$804K 0.06% 477
2018
Q4 		– Sell
-19,415
Closed -$145K – 1503
2018
Q3 		$145K Buy
19,415
+6,730
+53% +$47.8K 0.01% 1241
2018
Q2 		$75K Buy
+12,685
New +$72.3K ﹤0.01% 1311
2017
Q3 		– Sell
-18,848
Closed -$76K – 1506
2017
Q2 		$76K Sell
18,848
-4,701
-20% -$22.3K ﹤0.01% 1277
2017
Q1 		$133K Buy
+23,549
New +$149K 0.01% 1236
2016
Q1 		– Sell
-84,563
Closed -$914K – 1526
2015
Q4 		$914K Sell
84,563
-6,644
-7% -$65.2K 0.04% 606
2015
Q3 		$739K Buy
91,207
+72,539
+389% +$1.14M 0.03% 734
2015
Q2 		$451K Buy
+18,668
New +$589K 0.02% 1027
2014
Q4 		– Sell
-20,224
Closed -$495K – 1544
2014
Q3 		$495K Buy
20,224
+4,785
+31% +$135K 0.02% 754
2014
Q2 		$453K Sell
15,439
-23,326
-60% -$747K 0.02% 817
2014
Q1 		$1.71M Buy
38,765
+14,054
+57% +$618K 0.09% 309
2013
Q4 		$945K Buy
+24,711
New +$728K 0.05% 503
2013
Q3 		– Sell
-27,208
Closed -$475K – 1397
2013
Q2 		$475K Buy
+27,208
New +$477K 0.02% 893

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

A.R.T. Advisors's LAB Position: Q4 2019 in Review

A.R.T. Advisors sold out of Standard BioTools (LAB) in Q4 2019, closing a stake of 34,269 shares — an estimated $159K sold.

A.R.T. Advisors first reported a position in LAB in Q2 2013 and held it in 15 quarters. The position peaked at $1.71M in Q1 2014. 99 funds tracked by Wall St. Rank hold LAB as of Q4 2019.

  • A.R.T. Advisors reported no remaining Standard BioTools position as of Q4 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 34,269 Standard BioTools shares in Q4 2019, an estimated $159K.
  • A.R.T. Advisors first reported a position in Standard BioTools in Q2 2013 and held it in 15 quarters.
  • A.R.T. Advisors's Standard BioTools position peaked at $1.71M in Q1 2014.
  • 99 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.